Article Search
검색
검색 팝업 닫기

Metrics

Help

  • 1. Aims and Scope

    Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE

  • 2. Editorial Board

    Editor-in-Chief + MORE

    Editor-in-Chief
    Yong Chan Lee Professor of Medicine
    Director, Gastrointestinal Research Laboratory
    Veterans Affairs Medical Center, Univ. California San Francisco
    San Francisco, USA

    Deputy Editor

    Deputy Editor
    Jong Pil Im Seoul National University College of Medicine, Seoul, Korea
    Robert S. Bresalier University of Texas M. D. Anderson Cancer Center, Houston, USA
    Steven H. Itzkowitz Mount Sinai Medical Center, NY, USA
  • 3. Editorial Office
  • 4. Articles
  • 5. Instructions for Authors
  • 6. File Download (PDF version)
  • 7. Ethical Standards
  • 8. Peer Review

    All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
    The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.

    The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.

Search

Search

Year

to

Article Type

Original Article

Split Viewer

Electrohydraulic Lithotripsy for Difficult Bile Duct Stones under Endoscopic Retrograde Cholangiopancreatography and Peroral Transluminal Cholangioscopy Guidance

Rieko Kamiyama, Takeshi Ogura, Atsushi Okuda, Akira Miyano, Nobu Nishioka, Miyuki Imanishi, Wataru Takagi, and Kazuhide Higuchi

Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan

Correspondence to:Takeshi Ogura, Second Department of Internal Medicine, Osaka Medical College, 2-7 Daigakuchou, Takatsuki 569-8686, Japan, Tel: +81-726831221, Fax: +81-726846532, E-mail: oguratakeshi0411@yahoo.co.jp

Received: August 3, 2017; Revised: September 13, 2017; Accepted: September 27, 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Gut Liver 2018; 12(4): 457-462

Published online July 15, 2018 https://doi.org/10.5009/gnl17352

Copyright © Gut and Liver.

Background/Aims

Electrohydraulic lithotripsy (EHL) under endoscopic retrograde cholangiopancreatography (ERCP) guidance can be an option to treat difficult stones. Recently, a digital, single-operator cholangioscope (SPY-DS) has become available. Peroral transluminal cholangioscopy (PTLC) using SPY-DS has also been reported. In this retrospective study, the technical feasibility and clinical effectiveness of EHL for difficult bile duct stones under ERCP guidance and under PTLC guidance was examined.

Methods

In this pilot study, patients with difficult bile duct stones between July 2016 and July 2017 were retrospectively enrolled.

Results

Forty-two consecutive patients underwent EHL using a SPY-DS; 34 patients underwent EHL under ERCP guidance, and the other 8 patients underwent EHL under PTLC guidance. Median procedure time was 31 minutes (range, 19 to 66 minutes). The median number of EHL sessions was 1 (range, 1 to 2), and that of ERCP sessions was also 1 (range, 1 to 3). The rate of complete stone clearance was 98% (41/42). Adverse events such as cholangitis and acute pancreatitis were seen in 14% (6/42), which could be treated conservatively.

Conclusions

EHL using SPY-DS was technically feasible, not only under ERCP guidance, but also PTLC guidance. A prospective clinical study of EHL using SPY-DS is needed.

Keywords: Endoscopic ultrasound intervention, Cholangiopancreatography, endoscopic retrograde, Common bile duct, Choledcholithiasis

Bile duct stones are extremely common. They have a potential risk of acute cholangitis or pancreatitis, and they are usually treated under endoscopic retrograde cholangiopancreatography (ERCP) guidance.14 However, treating bile duct stones is sometimes challenging due to patient factor, such as surgically altered anatomy, a periampullary diverticulum, or a sigmoid-shaped common bile duct (CBD), and stones factors, such as a large number or size of stones, intrahepatic bile duct stones, or bile duct stenosis.5

Electrohydraulic lithotripsy (EHL) under ERCP guidance can be an option to treat difficult stones.69 Recently, a digital single-operator cholangioscope (SPY-DS; SpyGlass DS, Boston Scientific, Marlborough, MA, USA) has become available. The SPY-DS has several benefits: (1) easier insertion into the biliary tract due to the tapered tip; (2) good visualization through a digital field of view of 120°; and (3) newly added injection and suction functions performed via a 2-port adaptor. This system thus allows the performance of EHL even for intrahepatic bile duct stones.10,11 However, if the endoscope cannot be advanced into the ampulla of Vater due to surgically altered anatomy, bile duct stone removal is also challenging. Recently, endoscopic ultrasound-guided biliary drainage (EUS-BD) such as EUS-guided hepaticogastrostomy (EUS-HGS) has been developed,12 and antegrade stone removal has been reported using EUS-BD technique.13,14 As an advanced and novel technique, peroral transluminal cholangioscopy (PTLC) has been also reported.15 PTLC is performed using a SPY-DS through a fistula between the intrahepatic bile duct and the stomach or intestine.

In this retrospective study, the clinical feasibility and safety of EHL for difficult bile duct stones under ERCP guidance and under PTLC guidance were evaluated.

In this pilot study, between July 2016 and July 2017, patients who were complicated with difficult bile duct stones were retrospectively enrolled. All patients provided their written, informed consent to participate before the procedure. This study was approved by the Institutional Review Board of Osaka Medical College Hospital.

1. Technique of EHL under ERCP guidance

Indications for EHL under ERCP guidance were as follows: (1) large or multiple bile duct stones; (2) intrahepatic bile duct stone; (3) confluence stone; and (4) the presence of a bile duct stricture. First, a duodenoscope (JF260V; Olympus Optical, Tokyo, Japan) was advanced to the ampulla of Vater, and an ERCP catheter (MTW Endoskopie, Düsseldorf, Germany) was inserted into the CBD. Next, a 0.025-inch guidewire (VisiGlide; Olympus Medical Systems, Tokyo, Japan) was placed in the biliary tract. After cholangiography, endoscopic sphincterotomy was performed. An electrohydraulic shock wave generator (Lithotron EL27; Walz Elektronik Gmbh, Herrenberg, Germany) was used to generate shock waves of increasing frequency, which were applied as a continuous sequence of discharges during EHL. A 2.4-F EHL probe was used, and EHL was performed under SPY-DS guidance. To detect bile duct stones more easily, the SPY-DS was used with the mother-baby method, as previously reported.10 With the combination of operators, bile duct stones can be easily targeted.

After fragmentation, bile duct stone removal was performed using standard techniques, such as a basket or balloon catheter. Fig. 1 shows a confluence stone, which was difficult to treat by standard technique. Cholangiography showed a defect lesion, which suggested a bile duct stone with a diameter of 25 mm. First, the SPY-DS was inserted into the biliary tract, and the stone could be observed. Then, EHL was performed under SPY-DS guidance, and stone fragmentation could be obtained. Finally, stone removal was performed using a basket and a balloon catheter, and complete stone clearance was successfully obtained.

2. Technique of EHL under PTLC guidance

Indications for EHL under PTLC guidance were as follows: (1) ERCP could not be performed due to an inaccessible papilla because of surgically altered anatomy or duodenal obstruction; or (2) a large stone that could not be removed by standard techniques such as a balloon or a basket catheter. In this technique, several steps were needed. First, a fistula had to be created between the biliary tract and stomach. Second, EHL was performed through this fistula. To perform PTLC, EUS-HGS should be performed first. The echoendoscope (GF-UCT260; Olympus Optical) was inserted into the stomach, and the intrahepatic bile duct was detected. Then, the intrahepatic bile duct was punctured using a 19-gauge fine needle aspiration (Sono Tip Pro Control 19G; Medi-Globe GmbH, Achenmühle, Germany; Medico’s Hirata, Osaka, Japan) needle using color Doppler to avoid puncturing any vessels. After the bile juice was aspirated, the contrast medium was injected (Fig. 2A). After obtaining the image of the biliary tract, the bile duct and stomach wall were dilated using a balloon catheter (REN biliary dilation catheter; Kaneka, Osaka, Japan) or an ERCP catheter (MTW Endoskopie) (Fig. 2B). Stent placement was performed from the intrahepatic bile duct to the stomach (EUS-HGS) using a fully covered metal stent (10 mm×100 mm, End-bare type, Niti-S Biliary Cover Stent; TaeWoong Medical, Seoul, Korea; Century Medical, Tokyo, Japan) (Fig. 2C). Although a 10 cm-long EUS-HGS stent is useful to prevent stent migration, as previously reported,16,17 this stent has a limitation in that it is difficult to insert any devices through the stent. Therefore, if devices could not be inserted through the stent, the stent was trimmed, or the mesh of the stent was ruptured, as previously described.18,19

After the ERCP catheter was inserted into the EUS-HGS stent, the 0.025-inch guidewire (VisiGlide; Olympus Medical Systems) was advanced into the intestine across the ampulla of Vater, and the contrast medium was injected. If the CBD stone was small, antegrade stone extraction could be performed using a balloon catheter. However, if the CBD stones was large (Fig. 2A), antegrade stone extraction could not be performed using only a balloon catheter. Therefore, stone fragmentation was needed. The SPY-DS was antegradely inserted into the CBD, and the stone was visualized (Fig. 2B and C). EHL was then performed (Fig. 3A). After stone fragmentation, the ampulla of Vater was also dilated using a balloon catheter (Fig. 3B). Lastly, antegrade stone extraction was performed. If the stones were extremely small after EHL, stone extraction was performed through the EUS-HGS stent. During this procedure, to fit the axis, the guidewire was advanced into third part of the duodenum (Fig. 3C). After stone removal, the metal stent was exchanged to a plastic stent (Type IT, 7 F, 12 cm; Gadelius Medical Co. Ltd., Tokyo, Japan) to maintain the fistula.20

3. Definitions

Stone size was measured by computed tomography or abdominal ultrasound. The number of bile duct stones was also counted on cholangiography. Procedure time was measured from SPY-DS insertion to removal of the duodenoscope with both ERCP and PTLC guidance. Technical success was defined as successful fragmentation using EHL under ERCP or PTLC guidance with a SPY-DS. Descriptive statistics are shown as means±standard deviations or medians and range, as appropriate. Finally, adverse events were graded according to the American Society for Gastrointestinal Endoscopy lexicon’s severity grading system.21

Table 1 shows the patients’ characteristics. A total of 42 consecutive patients (27 male, 15 female) with a mean age of 77.1 years underwent EHL using the SPY-DS; 34 patients underwent EHL under ERCP guidance, and the other eight patients underwent EHL under PTLC guidance. Indications for EHL under ERCP guidance were as follows: large, multiple stones (n=18), confluence stone (n=8), intrahepatic bile duct stones (n=6), presence of bile duct stone upstream of a biliary stricture (n=1), and basket impaction (n=1). On the other hand, indications for EHL under PTLC guidance were as follows: surgically altered anatomy (n=7), and malignant duodenal obstruction (n=1).

The maximum median stone size was 27 mm (range, 12 to 37 mm), and the number of stones was as follows: 1 (n=18), 2 (n=6), 3 (n=6), 4 (n=2), >4 (n=2). The median procedure time was 31 minutes (range, 19 to 66 minutes). Technical success was achieved in all patients. The median number of EHL sessions was 1 (range, 1 to 2), and that of ERCP sessions was also 1 (range, 1 to 3). The rate of complete stone clearance was 98% (41/42). One patient who failed complete bile duct stone clearance had a biliary stricture, and multiple stones were seen upstream of this stricture (Fig. 4A). To access the bile duct stone, fully covered metal stent placement was performed (Fig. 4B), and then the SPY-DS was inserted. Since a large bile duct stone was seen, EHL was also performed (Fig. 4C–E). Although many bile duct stones could be removed, complete stone clearance could not be achieved (Fig. 4F). This patient underwent surgical treatment. Finally, adverse events such as cholangitis and acute pancreatitis were seen in 14% (6/42), which could be treated conservatively.

Approximately 10% to 15% of bile duct stones cannot be treated using standard stone removal techniques such as a basket or a balloon catheter. For such difficult stones, EHL has a clinical impact in obtaining stone fragmentation. However, EHL may also be difficult for challenging cases, such as intrahepatic bile duct stones, using a conventional cholangioscope because of limited operability due to two-way deflection and easy breakage. To overcome this problem, the SPY-DS, which has good operability with four-way deflection, and is not as fragile, has become available. However, there have not been enough reports of clinical evaluations of EHL using this scope only for the treatment of bile duct stones. Tanaka et al.10 reported a single-center, retrospective experience with a SPY-DS for diagnostic and therapeutic procedures. In that report, stone fragmentation was successfully performed by laser or EHL with the SPY-DS in 26 patients. Navaneethan et al.22 reported their experience with the SPY-DS in a multi-center, observational study of 105 patients. Among them, 31 patients with difficult bile duct stones underwent stone therapy by laser lithotripsy. Complete duct clearance in 1 session was achieved in 27 patients (87.1%). As study including only bile duct stone treatment, Wong et al.23 reported laser lithotripsy with the SPY-DS under ERCP guidance. In their study, 17 patients with difficult stones were prospectively enrolled. The overall stone clearance rate was 94% (16/17), and the rate of adverse events was 12% (2/17). This result was similar to present study, although there were differences, such as EHL and laser lithotripsy. However, the indication for EHL with the SPY-DS for intrahepatic bile duct stones may be limited for relatively proximal sites. Therefore, peripheral bile duct stones may not be appropriate for this approach, and this is a limitation of this method. Although the present study included a larger number of patients than these previous reports, the critical limitation of the present study is that it was retrospective. Therefore, the present results need to be confirmed by a prospective, multicenter study with a large number of patients.

In addition, the treatment of bile duct stones in patients with surgically altered anatomy is sometimes challenging. Percutaneous transhepatic drainage or a surgical approach has been used to treat such bile duct stones. Recently, single-balloon or double-balloon enteroscopy-assisted ERCP has emerged. However, although bile duct stones in patients with surgically altered anatomy may be treated using this technique, the technical success rate is less than 90%,14 even at high-volume centers or when performed by skilled endoscopists. In the remaining 10%, an alternative method is needed.

Recently, EUS-BD has been developed as an alternative method of biliary drainage under ERCP guidance.12 More recently, antegrade stone removal under EUS-guided biliary access has emerged. This technique has several advantages: (1) short procedure time compared with balloon enteroscopy; (2) ease of reintervention if the tract is maintained using a stent or after completion of a fistula between the bile duct and the gastrointestinal tract; and (3) cosmetic issues.13 Iwashita et al.14 reported the use of EUS-guided antegrade (EUS-AS) approach for bile duct stones in patients with surgically altered anatomy in a multicenter, retrospective, cohort study. In their study of 29 patients, 23 were successfully treated by EUS-AS. The median maximum size of the bile duct stones was 10 mm. Adverse adverse events were as follows: mild abdominal pain (n=2); bile peritonitis (n=1); cholecystitis (n=1); and elevation of serum C-reactive protein (n=1). EUS-AS was performed using a balloon catheter after endoscopic papillary balloon dilation in this study. However, if the size of stone is large, it might be difficult to remove the stone using only this technique. Itoi et al.13 reported the successful treatment of a large bile duct stone under EUS-AS guidance. They inserted an over-the-wire type mechanical lithotripsy device into the CBD through a fistula between the intrahepatic bile duct and the jejunum. Although this technique was creative and impressive, there were several concerns. First, this technique cannot be performed for larger bile duct stones. Second, during performance of the stone fragmentation, the risk of bile juice leakage across the fistula may be increased. On the other hand, the present technique has several advantages. First, because of covered metal stent placement, the risk of bile leak during and after EUS-AS may be lower than with the previous technique. Second, stone removal can be performed even if the size of the bile duct stone is large. To the best of our knowledge, this is also the first report of the performance of EHL under antegrade EUS guidance.

In conclusion, EHL using a SPY-DS was technically feasible, not only with ERCP guidance, but also with PTLC guidance. A prospective, multicenter, clinical study of EHL using a SPY-DS is needed.

No potential conflict of interest relevant to this article was reported.

Fig. 1.(A) Cholangiography showing a large stone at the confluence of the bile duct. (B) Electrohydraulic lithotripsy image of the cholangiography. (C) Electrohydraulic lithotripsy image of the cholangioscope. (D) After the fragmentation of the bile duct stone, the stone removal is performed using a standard technique. (E) Complete stone clearance was achieved.
Fig. 2.(A) The intrahepatic bile duct is punctured, and the guidewire is inserted into the biliary tract. (B) Endoscopic ultrasound-guided hepaticogastrostomy is performed using a fully covered metal stent. (C) Large stones are observed during the endoscopic ultrasound-guided hepaticogastrostomy.
Fig. 3.(A) The digital single-operator cholangioscope (SpyGlass DS, Boston Scientific) is antegradely inserted into the common bile duct, and electrohydraulic lithotripsy is performed antegradely. (B) Balloon dilation of the ampulla of Vater is performed. (C) Stone extraction is performed antegradely.
Fig. 4.(A) Bile duct stones are observed upstream of the bile duct. (B) A fully covered metal stent is inserted across the stricture site. (C) A digital single-operator cholangioscope (SpyGlass DS, Boston Scientific) is inserted into the intrahepatic bile duct through the metal stent. (D) Electrohydraulic lithotripsy is performed. (E) Fragmentation of stones is performed. (F) Complete stone clearance has failed (arrow).

Patient Characteristics

VariableValue
Total no. of patients42
Age, yr77.1±11.8
Sex, male:female27:15
Indication of EHL under ERCP guidance (n=34)
 Large, multiple stone18
 Confluence stone8
 Intrahepatic bile duct stone6
  Left intrahepatic bile duct4
  Right intrahepatic bile duct1
  B31
 Presence of bile duct stone upstream of biliary stricture1
 Basket impaction1
Indication of EHL under PTLC guidance (n=8)
 Surgically altered anatomy7
 Malignant duodenal obstruction1
Maximum stone size, mm27 (12–37)
No. of stones
 1:2:3:4:>418:6:6:2:2
Procedure time, min31 (19–66)
Technical success28/28 (100)
No. of EHL session1 (1–2)
No. of ERCP session1 (1–3)
Rate of complete stone clearance*41/42 (98)
Adverse events
 Cholangitis5
 Acute pancreatitis1

Data are presented as number, mean±SD, or median (range).

EHL, electrohydraulic lithotripsy; ERCP, endoscopic retrograde cholangiopancreatography; PTLC, peroral transluminal cholangioscopy.

*Number/total number (%).


  1. Yasuda, I, and Itoi, T (2013). Recent advances in endoscopic management of difficult bile duct stones. Dig Endosc. 25, 376-385.
    Pubmed CrossRef
  2. Trikudanathan, G, Navaneethan, U, and Parsi, MA (2013). Endoscopic management of difficult common bile duct stones. World J Gastroenterol. 19, 165-173.
    Pubmed KoreaMed CrossRef
  3. Buxbaum, J (2013). Modern management of common bile duct stones. Gastrointest Endosc Clin N Am. 23, 251-275.
    Pubmed CrossRef
  4. Katanuma, A, Maguchi, H, Osanai, M, and Takahashi, K (2010). Endoscopic treatment of difficult common bile duct stones. Dig Endosc. 22, S90-S97.
    Pubmed CrossRef
  5. Ogura, T, and Higuchi, K (2016). A review of treatment options for bile duct stones. Expert Rev Gastroenterol Hepatol. 10, 1271-1278.
    Pubmed CrossRef
  6. Leung, JW, and Chung, SS (1989). Electrohydraulic lithotripsy with peroral choledochoscopy. BMJ. 299, 595-598.
    Pubmed KoreaMed CrossRef
  7. Binmoeller, KF, Brückner, M, Thonke, F, and Soehendra, N (1993). Treatment of difficult bile duct stones using mechanical, electrohydraulic and extracorporeal shock wave lithotripsy. Endoscopy. 25, 201-206.
    Pubmed CrossRef
  8. Adamek, HE, Maier, M, Jakobs, R, Wessbecher, FR, Neuhauser, T, and Riemann, JF (1996). Management of retained bile duct stones: a prospective open trial comparing extracorporeal and intracorporeal lithotripsy. Gastrointest Endosc. 44, 40-47.
    Pubmed CrossRef
  9. Hui, CK, Lai, KC, and Ng, M (2003). Retained common bile duct stones: a comparison between biliary stenting and complete clearance of stones by electrohydraulic lithotripsy. Aliment Pharmacol Ther. 17, 289-296.
    Pubmed CrossRef
  10. Tanaka, R, Itoi, T, and Honjo, M (2016). New digital cholangiopancreatoscopy for diagnosis and therapy of pancreaticobiliary diseases (with videos). J Hepatobiliary Pancreat Sci. 23, 220-226.
    Pubmed CrossRef
  11. Ogura, T, Imanishi, M, and Kurisu, Y (2017). Prospective evaluation of digital single-operator cholangioscope for diagnostic and therapeutic procedures (with videos). Dig Endosc. 29, 782-789.
    Pubmed CrossRef
  12. Khashab, MA, Van der Merwe, S, and Kunda, R (2016). Prospective international multicenter study on endoscopic ultrasound-guided biliary drainage for patients with malignant distal biliary obstruction after failed endoscopic retrograde cholangiopancreatography. Endosc Int Open. 4, E487-E496.
    Pubmed KoreaMed CrossRef
  13. Itoi, T, Sofuni, A, Tsuchiya, T, Ijima, M, and Iwashita, T (2014). Endoscopic ultrasonography-guided transhepatic antegrade stone removal in patients with surgically altered anatomy: case series and technical review (with videos). J Hepatobiliary Pancreat Sci. 21, E86-E93.
    Pubmed CrossRef
  14. Iwashita, T, Nakai, Y, Hara, K, Isayama, H, Itoi, T, and Park, DH (2016). Endoscopic ultrasound-guided antegrade treatment of bile duct stone in patients with surgically altered anatomy: a multicenter retrospective cohort study. J Hepatobiliary Pancreat Sci. 23, 227-233.
    Pubmed CrossRef
  15. Ogura, T, Takagi, W, Kurisu, Y, and Higuchi, K (2016). Technical tips for peroral transluminal cholangioscopy using novel single-operator cholangioscope (with videos). J Hepatobiliary Pancreat Sci. 23, E25-E29.
    Pubmed CrossRef
  16. Ogura, T, Yamamoto, K, and Sano, T (2015). Stent length is impact factor associated with stent patency in endoscopic ultrasound-guided hepaticogastrostomy. J Gastroenterol Hepatol. 30, 1748-1752.
    Pubmed CrossRef
  17. Nakai, Y, Isayama, H, and Yamamoto, N (2016). Safety and effectiveness of a long, partially covered metal stent for endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction. Endoscopy. 48, 1125-1128.
    Pubmed CrossRef
  18. Ogura, T, Masuda, D, Takeuchi, T, Fukunishi, S, and Higuchi, K (2016). Simplified reintervention method of EUS-guided hepaticogastrostomy stent obstruction. Gastrointest Endosc. 83, 831.
    CrossRef
  19. Minaga, K, Takenaka, M, Miyata, T, Ueda, Y, Kitano, M, and Kudo, M (2016). Through-the-mesh technique after endoscopic ultrasonography-guided hepaticogastrostomy: a novel re-intervention method. Endoscopy. 48, E369-E370.
    Pubmed CrossRef
  20. Umeda, J, Itoi, T, and Tsuchiya, T (2015). A newly designed plastic stent for EUS-guided hepaticogastrostomy: a prospective preliminary feasibility study (with videos). Gastrointest Endosc. 82, 390-396.e2.
    Pubmed CrossRef
  21. Cotton, PB, Eisen, GM, and Aabakken, L (2010). A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 71, 446-454.
    Pubmed CrossRef
  22. Navaneethan, U, Hasan, MK, and Kommaraju, K (2016). Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video). Gastrointest Endosc. 84, 649-655.
    Pubmed CrossRef
  23. Wong, JC, Tang, RS, Teoh, AY, Sung, JJ, and Lau, JY (2017). Efficacy and safety of novel digital single-operator peroral cholangioscopy-guided laser lithotripsy for complicated biliary stones. Endosc Int Open. 5, E54-E58.
    Pubmed KoreaMed CrossRef

Article

Original Article

Gut and Liver 2018; 12(4): 457-462

Published online July 15, 2018 https://doi.org/10.5009/gnl17352

Copyright © Gut and Liver.

Electrohydraulic Lithotripsy for Difficult Bile Duct Stones under Endoscopic Retrograde Cholangiopancreatography and Peroral Transluminal Cholangioscopy Guidance

Rieko Kamiyama, Takeshi Ogura, Atsushi Okuda, Akira Miyano, Nobu Nishioka, Miyuki Imanishi, Wataru Takagi, and Kazuhide Higuchi

Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan

Correspondence to:Takeshi Ogura, Second Department of Internal Medicine, Osaka Medical College, 2-7 Daigakuchou, Takatsuki 569-8686, Japan, Tel: +81-726831221, Fax: +81-726846532, E-mail: oguratakeshi0411@yahoo.co.jp

Received: August 3, 2017; Revised: September 13, 2017; Accepted: September 27, 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background/Aims

Electrohydraulic lithotripsy (EHL) under endoscopic retrograde cholangiopancreatography (ERCP) guidance can be an option to treat difficult stones. Recently, a digital, single-operator cholangioscope (SPY-DS) has become available. Peroral transluminal cholangioscopy (PTLC) using SPY-DS has also been reported. In this retrospective study, the technical feasibility and clinical effectiveness of EHL for difficult bile duct stones under ERCP guidance and under PTLC guidance was examined.

Methods

In this pilot study, patients with difficult bile duct stones between July 2016 and July 2017 were retrospectively enrolled.

Results

Forty-two consecutive patients underwent EHL using a SPY-DS; 34 patients underwent EHL under ERCP guidance, and the other 8 patients underwent EHL under PTLC guidance. Median procedure time was 31 minutes (range, 19 to 66 minutes). The median number of EHL sessions was 1 (range, 1 to 2), and that of ERCP sessions was also 1 (range, 1 to 3). The rate of complete stone clearance was 98% (41/42). Adverse events such as cholangitis and acute pancreatitis were seen in 14% (6/42), which could be treated conservatively.

Conclusions

EHL using SPY-DS was technically feasible, not only under ERCP guidance, but also PTLC guidance. A prospective clinical study of EHL using SPY-DS is needed.

Keywords: Endoscopic ultrasound intervention, Cholangiopancreatography, endoscopic retrograde, Common bile duct, Choledcholithiasis

INTRODUCTION

Bile duct stones are extremely common. They have a potential risk of acute cholangitis or pancreatitis, and they are usually treated under endoscopic retrograde cholangiopancreatography (ERCP) guidance.14 However, treating bile duct stones is sometimes challenging due to patient factor, such as surgically altered anatomy, a periampullary diverticulum, or a sigmoid-shaped common bile duct (CBD), and stones factors, such as a large number or size of stones, intrahepatic bile duct stones, or bile duct stenosis.5

Electrohydraulic lithotripsy (EHL) under ERCP guidance can be an option to treat difficult stones.69 Recently, a digital single-operator cholangioscope (SPY-DS; SpyGlass DS, Boston Scientific, Marlborough, MA, USA) has become available. The SPY-DS has several benefits: (1) easier insertion into the biliary tract due to the tapered tip; (2) good visualization through a digital field of view of 120°; and (3) newly added injection and suction functions performed via a 2-port adaptor. This system thus allows the performance of EHL even for intrahepatic bile duct stones.10,11 However, if the endoscope cannot be advanced into the ampulla of Vater due to surgically altered anatomy, bile duct stone removal is also challenging. Recently, endoscopic ultrasound-guided biliary drainage (EUS-BD) such as EUS-guided hepaticogastrostomy (EUS-HGS) has been developed,12 and antegrade stone removal has been reported using EUS-BD technique.13,14 As an advanced and novel technique, peroral transluminal cholangioscopy (PTLC) has been also reported.15 PTLC is performed using a SPY-DS through a fistula between the intrahepatic bile duct and the stomach or intestine.

In this retrospective study, the clinical feasibility and safety of EHL for difficult bile duct stones under ERCP guidance and under PTLC guidance were evaluated.

MATERIALS AND METHODS

In this pilot study, between July 2016 and July 2017, patients who were complicated with difficult bile duct stones were retrospectively enrolled. All patients provided their written, informed consent to participate before the procedure. This study was approved by the Institutional Review Board of Osaka Medical College Hospital.

1. Technique of EHL under ERCP guidance

Indications for EHL under ERCP guidance were as follows: (1) large or multiple bile duct stones; (2) intrahepatic bile duct stone; (3) confluence stone; and (4) the presence of a bile duct stricture. First, a duodenoscope (JF260V; Olympus Optical, Tokyo, Japan) was advanced to the ampulla of Vater, and an ERCP catheter (MTW Endoskopie, Düsseldorf, Germany) was inserted into the CBD. Next, a 0.025-inch guidewire (VisiGlide; Olympus Medical Systems, Tokyo, Japan) was placed in the biliary tract. After cholangiography, endoscopic sphincterotomy was performed. An electrohydraulic shock wave generator (Lithotron EL27; Walz Elektronik Gmbh, Herrenberg, Germany) was used to generate shock waves of increasing frequency, which were applied as a continuous sequence of discharges during EHL. A 2.4-F EHL probe was used, and EHL was performed under SPY-DS guidance. To detect bile duct stones more easily, the SPY-DS was used with the mother-baby method, as previously reported.10 With the combination of operators, bile duct stones can be easily targeted.

After fragmentation, bile duct stone removal was performed using standard techniques, such as a basket or balloon catheter. Fig. 1 shows a confluence stone, which was difficult to treat by standard technique. Cholangiography showed a defect lesion, which suggested a bile duct stone with a diameter of 25 mm. First, the SPY-DS was inserted into the biliary tract, and the stone could be observed. Then, EHL was performed under SPY-DS guidance, and stone fragmentation could be obtained. Finally, stone removal was performed using a basket and a balloon catheter, and complete stone clearance was successfully obtained.

2. Technique of EHL under PTLC guidance

Indications for EHL under PTLC guidance were as follows: (1) ERCP could not be performed due to an inaccessible papilla because of surgically altered anatomy or duodenal obstruction; or (2) a large stone that could not be removed by standard techniques such as a balloon or a basket catheter. In this technique, several steps were needed. First, a fistula had to be created between the biliary tract and stomach. Second, EHL was performed through this fistula. To perform PTLC, EUS-HGS should be performed first. The echoendoscope (GF-UCT260; Olympus Optical) was inserted into the stomach, and the intrahepatic bile duct was detected. Then, the intrahepatic bile duct was punctured using a 19-gauge fine needle aspiration (Sono Tip Pro Control 19G; Medi-Globe GmbH, Achenmühle, Germany; Medico’s Hirata, Osaka, Japan) needle using color Doppler to avoid puncturing any vessels. After the bile juice was aspirated, the contrast medium was injected (Fig. 2A). After obtaining the image of the biliary tract, the bile duct and stomach wall were dilated using a balloon catheter (REN biliary dilation catheter; Kaneka, Osaka, Japan) or an ERCP catheter (MTW Endoskopie) (Fig. 2B). Stent placement was performed from the intrahepatic bile duct to the stomach (EUS-HGS) using a fully covered metal stent (10 mm×100 mm, End-bare type, Niti-S Biliary Cover Stent; TaeWoong Medical, Seoul, Korea; Century Medical, Tokyo, Japan) (Fig. 2C). Although a 10 cm-long EUS-HGS stent is useful to prevent stent migration, as previously reported,16,17 this stent has a limitation in that it is difficult to insert any devices through the stent. Therefore, if devices could not be inserted through the stent, the stent was trimmed, or the mesh of the stent was ruptured, as previously described.18,19

After the ERCP catheter was inserted into the EUS-HGS stent, the 0.025-inch guidewire (VisiGlide; Olympus Medical Systems) was advanced into the intestine across the ampulla of Vater, and the contrast medium was injected. If the CBD stone was small, antegrade stone extraction could be performed using a balloon catheter. However, if the CBD stones was large (Fig. 2A), antegrade stone extraction could not be performed using only a balloon catheter. Therefore, stone fragmentation was needed. The SPY-DS was antegradely inserted into the CBD, and the stone was visualized (Fig. 2B and C). EHL was then performed (Fig. 3A). After stone fragmentation, the ampulla of Vater was also dilated using a balloon catheter (Fig. 3B). Lastly, antegrade stone extraction was performed. If the stones were extremely small after EHL, stone extraction was performed through the EUS-HGS stent. During this procedure, to fit the axis, the guidewire was advanced into third part of the duodenum (Fig. 3C). After stone removal, the metal stent was exchanged to a plastic stent (Type IT, 7 F, 12 cm; Gadelius Medical Co. Ltd., Tokyo, Japan) to maintain the fistula.20

3. Definitions

Stone size was measured by computed tomography or abdominal ultrasound. The number of bile duct stones was also counted on cholangiography. Procedure time was measured from SPY-DS insertion to removal of the duodenoscope with both ERCP and PTLC guidance. Technical success was defined as successful fragmentation using EHL under ERCP or PTLC guidance with a SPY-DS. Descriptive statistics are shown as means±standard deviations or medians and range, as appropriate. Finally, adverse events were graded according to the American Society for Gastrointestinal Endoscopy lexicon’s severity grading system.21

RESULTS

Table 1 shows the patients’ characteristics. A total of 42 consecutive patients (27 male, 15 female) with a mean age of 77.1 years underwent EHL using the SPY-DS; 34 patients underwent EHL under ERCP guidance, and the other eight patients underwent EHL under PTLC guidance. Indications for EHL under ERCP guidance were as follows: large, multiple stones (n=18), confluence stone (n=8), intrahepatic bile duct stones (n=6), presence of bile duct stone upstream of a biliary stricture (n=1), and basket impaction (n=1). On the other hand, indications for EHL under PTLC guidance were as follows: surgically altered anatomy (n=7), and malignant duodenal obstruction (n=1).

The maximum median stone size was 27 mm (range, 12 to 37 mm), and the number of stones was as follows: 1 (n=18), 2 (n=6), 3 (n=6), 4 (n=2), >4 (n=2). The median procedure time was 31 minutes (range, 19 to 66 minutes). Technical success was achieved in all patients. The median number of EHL sessions was 1 (range, 1 to 2), and that of ERCP sessions was also 1 (range, 1 to 3). The rate of complete stone clearance was 98% (41/42). One patient who failed complete bile duct stone clearance had a biliary stricture, and multiple stones were seen upstream of this stricture (Fig. 4A). To access the bile duct stone, fully covered metal stent placement was performed (Fig. 4B), and then the SPY-DS was inserted. Since a large bile duct stone was seen, EHL was also performed (Fig. 4C–E). Although many bile duct stones could be removed, complete stone clearance could not be achieved (Fig. 4F). This patient underwent surgical treatment. Finally, adverse events such as cholangitis and acute pancreatitis were seen in 14% (6/42), which could be treated conservatively.

DISCUSSION

Approximately 10% to 15% of bile duct stones cannot be treated using standard stone removal techniques such as a basket or a balloon catheter. For such difficult stones, EHL has a clinical impact in obtaining stone fragmentation. However, EHL may also be difficult for challenging cases, such as intrahepatic bile duct stones, using a conventional cholangioscope because of limited operability due to two-way deflection and easy breakage. To overcome this problem, the SPY-DS, which has good operability with four-way deflection, and is not as fragile, has become available. However, there have not been enough reports of clinical evaluations of EHL using this scope only for the treatment of bile duct stones. Tanaka et al.10 reported a single-center, retrospective experience with a SPY-DS for diagnostic and therapeutic procedures. In that report, stone fragmentation was successfully performed by laser or EHL with the SPY-DS in 26 patients. Navaneethan et al.22 reported their experience with the SPY-DS in a multi-center, observational study of 105 patients. Among them, 31 patients with difficult bile duct stones underwent stone therapy by laser lithotripsy. Complete duct clearance in 1 session was achieved in 27 patients (87.1%). As study including only bile duct stone treatment, Wong et al.23 reported laser lithotripsy with the SPY-DS under ERCP guidance. In their study, 17 patients with difficult stones were prospectively enrolled. The overall stone clearance rate was 94% (16/17), and the rate of adverse events was 12% (2/17). This result was similar to present study, although there were differences, such as EHL and laser lithotripsy. However, the indication for EHL with the SPY-DS for intrahepatic bile duct stones may be limited for relatively proximal sites. Therefore, peripheral bile duct stones may not be appropriate for this approach, and this is a limitation of this method. Although the present study included a larger number of patients than these previous reports, the critical limitation of the present study is that it was retrospective. Therefore, the present results need to be confirmed by a prospective, multicenter study with a large number of patients.

In addition, the treatment of bile duct stones in patients with surgically altered anatomy is sometimes challenging. Percutaneous transhepatic drainage or a surgical approach has been used to treat such bile duct stones. Recently, single-balloon or double-balloon enteroscopy-assisted ERCP has emerged. However, although bile duct stones in patients with surgically altered anatomy may be treated using this technique, the technical success rate is less than 90%,14 even at high-volume centers or when performed by skilled endoscopists. In the remaining 10%, an alternative method is needed.

Recently, EUS-BD has been developed as an alternative method of biliary drainage under ERCP guidance.12 More recently, antegrade stone removal under EUS-guided biliary access has emerged. This technique has several advantages: (1) short procedure time compared with balloon enteroscopy; (2) ease of reintervention if the tract is maintained using a stent or after completion of a fistula between the bile duct and the gastrointestinal tract; and (3) cosmetic issues.13 Iwashita et al.14 reported the use of EUS-guided antegrade (EUS-AS) approach for bile duct stones in patients with surgically altered anatomy in a multicenter, retrospective, cohort study. In their study of 29 patients, 23 were successfully treated by EUS-AS. The median maximum size of the bile duct stones was 10 mm. Adverse adverse events were as follows: mild abdominal pain (n=2); bile peritonitis (n=1); cholecystitis (n=1); and elevation of serum C-reactive protein (n=1). EUS-AS was performed using a balloon catheter after endoscopic papillary balloon dilation in this study. However, if the size of stone is large, it might be difficult to remove the stone using only this technique. Itoi et al.13 reported the successful treatment of a large bile duct stone under EUS-AS guidance. They inserted an over-the-wire type mechanical lithotripsy device into the CBD through a fistula between the intrahepatic bile duct and the jejunum. Although this technique was creative and impressive, there were several concerns. First, this technique cannot be performed for larger bile duct stones. Second, during performance of the stone fragmentation, the risk of bile juice leakage across the fistula may be increased. On the other hand, the present technique has several advantages. First, because of covered metal stent placement, the risk of bile leak during and after EUS-AS may be lower than with the previous technique. Second, stone removal can be performed even if the size of the bile duct stone is large. To the best of our knowledge, this is also the first report of the performance of EHL under antegrade EUS guidance.

In conclusion, EHL using a SPY-DS was technically feasible, not only with ERCP guidance, but also with PTLC guidance. A prospective, multicenter, clinical study of EHL using a SPY-DS is needed.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

Fig 1.

Figure 1.(A) Cholangiography showing a large stone at the confluence of the bile duct. (B) Electrohydraulic lithotripsy image of the cholangiography. (C) Electrohydraulic lithotripsy image of the cholangioscope. (D) After the fragmentation of the bile duct stone, the stone removal is performed using a standard technique. (E) Complete stone clearance was achieved.
Gut and Liver 2018; 12: 457-462https://doi.org/10.5009/gnl17352

Fig 2.

Figure 2.(A) The intrahepatic bile duct is punctured, and the guidewire is inserted into the biliary tract. (B) Endoscopic ultrasound-guided hepaticogastrostomy is performed using a fully covered metal stent. (C) Large stones are observed during the endoscopic ultrasound-guided hepaticogastrostomy.
Gut and Liver 2018; 12: 457-462https://doi.org/10.5009/gnl17352

Fig 3.

Figure 3.(A) The digital single-operator cholangioscope (SpyGlass DS, Boston Scientific) is antegradely inserted into the common bile duct, and electrohydraulic lithotripsy is performed antegradely. (B) Balloon dilation of the ampulla of Vater is performed. (C) Stone extraction is performed antegradely.
Gut and Liver 2018; 12: 457-462https://doi.org/10.5009/gnl17352

Fig 4.

Figure 4.(A) Bile duct stones are observed upstream of the bile duct. (B) A fully covered metal stent is inserted across the stricture site. (C) A digital single-operator cholangioscope (SpyGlass DS, Boston Scientific) is inserted into the intrahepatic bile duct through the metal stent. (D) Electrohydraulic lithotripsy is performed. (E) Fragmentation of stones is performed. (F) Complete stone clearance has failed (arrow).
Gut and Liver 2018; 12: 457-462https://doi.org/10.5009/gnl17352

Table 1 Patient Characteristics

VariableValue
Total no. of patients42
Age, yr77.1±11.8
Sex, male:female27:15
Indication of EHL under ERCP guidance (n=34)
 Large, multiple stone18
 Confluence stone8
 Intrahepatic bile duct stone6
  Left intrahepatic bile duct4
  Right intrahepatic bile duct1
  B31
 Presence of bile duct stone upstream of biliary stricture1
 Basket impaction1
Indication of EHL under PTLC guidance (n=8)
 Surgically altered anatomy7
 Malignant duodenal obstruction1
Maximum stone size, mm27 (12–37)
No. of stones
 1:2:3:4:>418:6:6:2:2
Procedure time, min31 (19–66)
Technical success28/28 (100)
No. of EHL session1 (1–2)
No. of ERCP session1 (1–3)
Rate of complete stone clearance*41/42 (98)
Adverse events
 Cholangitis5
 Acute pancreatitis1

Data are presented as number, mean±SD, or median (range).

EHL, electrohydraulic lithotripsy; ERCP, endoscopic retrograde cholangiopancreatography; PTLC, peroral transluminal cholangioscopy.

*Number/total number (%).


References

  1. Yasuda, I, and Itoi, T (2013). Recent advances in endoscopic management of difficult bile duct stones. Dig Endosc. 25, 376-385.
    Pubmed CrossRef
  2. Trikudanathan, G, Navaneethan, U, and Parsi, MA (2013). Endoscopic management of difficult common bile duct stones. World J Gastroenterol. 19, 165-173.
    Pubmed KoreaMed CrossRef
  3. Buxbaum, J (2013). Modern management of common bile duct stones. Gastrointest Endosc Clin N Am. 23, 251-275.
    Pubmed CrossRef
  4. Katanuma, A, Maguchi, H, Osanai, M, and Takahashi, K (2010). Endoscopic treatment of difficult common bile duct stones. Dig Endosc. 22, S90-S97.
    Pubmed CrossRef
  5. Ogura, T, and Higuchi, K (2016). A review of treatment options for bile duct stones. Expert Rev Gastroenterol Hepatol. 10, 1271-1278.
    Pubmed CrossRef
  6. Leung, JW, and Chung, SS (1989). Electrohydraulic lithotripsy with peroral choledochoscopy. BMJ. 299, 595-598.
    Pubmed KoreaMed CrossRef
  7. Binmoeller, KF, Brückner, M, Thonke, F, and Soehendra, N (1993). Treatment of difficult bile duct stones using mechanical, electrohydraulic and extracorporeal shock wave lithotripsy. Endoscopy. 25, 201-206.
    Pubmed CrossRef
  8. Adamek, HE, Maier, M, Jakobs, R, Wessbecher, FR, Neuhauser, T, and Riemann, JF (1996). Management of retained bile duct stones: a prospective open trial comparing extracorporeal and intracorporeal lithotripsy. Gastrointest Endosc. 44, 40-47.
    Pubmed CrossRef
  9. Hui, CK, Lai, KC, and Ng, M (2003). Retained common bile duct stones: a comparison between biliary stenting and complete clearance of stones by electrohydraulic lithotripsy. Aliment Pharmacol Ther. 17, 289-296.
    Pubmed CrossRef
  10. Tanaka, R, Itoi, T, and Honjo, M (2016). New digital cholangiopancreatoscopy for diagnosis and therapy of pancreaticobiliary diseases (with videos). J Hepatobiliary Pancreat Sci. 23, 220-226.
    Pubmed CrossRef
  11. Ogura, T, Imanishi, M, and Kurisu, Y (2017). Prospective evaluation of digital single-operator cholangioscope for diagnostic and therapeutic procedures (with videos). Dig Endosc. 29, 782-789.
    Pubmed CrossRef
  12. Khashab, MA, Van der Merwe, S, and Kunda, R (2016). Prospective international multicenter study on endoscopic ultrasound-guided biliary drainage for patients with malignant distal biliary obstruction after failed endoscopic retrograde cholangiopancreatography. Endosc Int Open. 4, E487-E496.
    Pubmed KoreaMed CrossRef
  13. Itoi, T, Sofuni, A, Tsuchiya, T, Ijima, M, and Iwashita, T (2014). Endoscopic ultrasonography-guided transhepatic antegrade stone removal in patients with surgically altered anatomy: case series and technical review (with videos). J Hepatobiliary Pancreat Sci. 21, E86-E93.
    Pubmed CrossRef
  14. Iwashita, T, Nakai, Y, Hara, K, Isayama, H, Itoi, T, and Park, DH (2016). Endoscopic ultrasound-guided antegrade treatment of bile duct stone in patients with surgically altered anatomy: a multicenter retrospective cohort study. J Hepatobiliary Pancreat Sci. 23, 227-233.
    Pubmed CrossRef
  15. Ogura, T, Takagi, W, Kurisu, Y, and Higuchi, K (2016). Technical tips for peroral transluminal cholangioscopy using novel single-operator cholangioscope (with videos). J Hepatobiliary Pancreat Sci. 23, E25-E29.
    Pubmed CrossRef
  16. Ogura, T, Yamamoto, K, and Sano, T (2015). Stent length is impact factor associated with stent patency in endoscopic ultrasound-guided hepaticogastrostomy. J Gastroenterol Hepatol. 30, 1748-1752.
    Pubmed CrossRef
  17. Nakai, Y, Isayama, H, and Yamamoto, N (2016). Safety and effectiveness of a long, partially covered metal stent for endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction. Endoscopy. 48, 1125-1128.
    Pubmed CrossRef
  18. Ogura, T, Masuda, D, Takeuchi, T, Fukunishi, S, and Higuchi, K (2016). Simplified reintervention method of EUS-guided hepaticogastrostomy stent obstruction. Gastrointest Endosc. 83, 831.
    CrossRef
  19. Minaga, K, Takenaka, M, Miyata, T, Ueda, Y, Kitano, M, and Kudo, M (2016). Through-the-mesh technique after endoscopic ultrasonography-guided hepaticogastrostomy: a novel re-intervention method. Endoscopy. 48, E369-E370.
    Pubmed CrossRef
  20. Umeda, J, Itoi, T, and Tsuchiya, T (2015). A newly designed plastic stent for EUS-guided hepaticogastrostomy: a prospective preliminary feasibility study (with videos). Gastrointest Endosc. 82, 390-396.e2.
    Pubmed CrossRef
  21. Cotton, PB, Eisen, GM, and Aabakken, L (2010). A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 71, 446-454.
    Pubmed CrossRef
  22. Navaneethan, U, Hasan, MK, and Kommaraju, K (2016). Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video). Gastrointest Endosc. 84, 649-655.
    Pubmed CrossRef
  23. Wong, JC, Tang, RS, Teoh, AY, Sung, JJ, and Lau, JY (2017). Efficacy and safety of novel digital single-operator peroral cholangioscopy-guided laser lithotripsy for complicated biliary stones. Endosc Int Open. 5, E54-E58.
    Pubmed KoreaMed CrossRef
Gut and Liver

Vol.16 No.1
January, 2022

pISSN 1976-2283
eISSN 2005-1212

qrcode
qrcode

Share this article on :

  • line

Popular Keywords

Gut and LiverQR code Download
qr-code

Editorial Office